さまよう薬剤師のブログ

学位を持っても、センスのない、感染制御専門薬剤師のブログ.  I have Ph.D. but less sense ID pharmacist.

RCT

First-Line Nivolumab in Stage IV or Recurrent Non-Small-Cell Lung Cancer.

プレゼンターは、呼吸器内科のボス。 2017年NEJMに発表された、IV 期または再発性の非小細胞肺癌に対する第一選択薬としてのニボルマブの報告。ネガティブスタディー。

β-Lactam monotherapy vs β-lactam-macrolide combination treatment in moderately severe community-acquired pneumonia: a randomized noninferiority trial

2014年 JAMA Intern Med に発表された、スウェーデン6施設で行われた 中症度CAPに対するβラクタム単剤治療とβラクタム+マクロライド併用治療の7日における臨床的安定性を確認した、非劣勢オープンラベルRCT。

Journal Club : Alectinib versus Crizotinib in Untreated ALK-Positive Non-Small-Cell Lung Cancer

今週のプレゼンターは、呼吸器内科医です。 2017年6月NEJMに発表された、 ALK陽性 非小細胞がんに対するアレクチニブ vs クリゾチニブの第3相RCT。 www.ncbi.nlm.nih.gov

Decolonization of intestinal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae with oral colistin and neomycin: a randomized, double-blind, placebo-controlled trial.

Decolonization of intestinal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae with oral colistin and neomycin: a randomized, double-blind, placebo-controlled trial. www.ncbi.nlm.nih.gov 2013年JACに報告された、スイス単…

Colistin and rifampicin compared with colistin alone for the treatment of serious infections due to extensively drug-resistant Acinetobacter baumannii: a multicenter, randomized clinical trial.

Colistin and rifampicin compared with colistin alone for the treatment of serious infections due to extensively drug-resistant Acinetobacter baumannii: a multicenter, randomized clinical trial. www.ncbi.nlm.nih.gov 2013年CIDに報告された、…

Continuous infusion of beta-lactam antibiotics in severe sepsis: a multicenter double-blind, randomized controlled trial.

Continuous infusion of beta-lactam antibiotics in severe sepsis: a multicenter double-blind, randomized controlled trial. www.ncbi.nlm.nih.gov 2013年 CID に報告された、オーストラリアと香港の5施設ICUによる重症sepsisに対しするベータラクタム…

Effect of Cephalexin Plus Trimethoprim-Sulfamethoxazole vs Cephalexin Alone on Clinical Cure of Uncomplicated Cellulitis: A Randomized Clinical Trial.

Effect of Cephalexin Plus Trimethoprim-Sulfamethoxazole vs Cephalexin Alone on Clinical Cure of Uncomplicated Cellulitis: A Randomized Clinical Trial. www.ncbi.nlm.nih.gov 2017年5月 JAMA に報告された、米国5施設による単純性蜂窩織炎に対しす…

Journal Club : A phase II randomized double-blind placebo-controlled study of 6-gingerol as an anti-emetic in solid tumor patients receiving moderately to highly emetogenic chemotherapy.

Journal Club : A phase II randomized double-blind placebo-controlled study of 6-gingerol as an anti-emetic in solid tumor patients receiving moderately to highly emetogenic chemotherapy. www.ncbi.nlm.nih.gov 今週のプレゼンターは、私です。 …

Journal Club : SALTO ; Randomised phase III trial of S-1 versus capecitabine in the first-line treatment of metastatic colorectal cancer: SALTO study by the Dutch Colorectal Cancer Group.

Journal Club : SALTO ; Randomised phase III trial of S-1 versus capecitabine in the first-line treatment of metastatic colorectal cancer: SALTO study by the Dutch Colorectal Cancer Group. www.ncbi.nlm.nih.gov 今週のプレゼンターは、薬学部5…

Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial.

Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial. www.ncbi.nlm.nih.gov 2016年5月 Lancet Inf Dis に報告された、オランダ15施…

SOLO I : Single-dose oritavancin in the treatment of acute bacterial skin infections.

SOLO I : Single-dose oritavancin in the treatment of acute bacterial skin infections. www.ncbi.nlm.nih.gov 2014年 NEJMに報告された、急性細菌性皮膚/皮膚組織感染症に対するoritavancinとvancomycinを比較したRCT。

ESTABLISH-2 : Tedizolid for 6 days versus linezolid for 10 days for acute bacterial skin and skin-structure infections (ESTABLISH-2): a randomised, double-blind, phase 3, non-inferiority trial.

ESTABLISH-2 : Tedizolid for 6 days versus linezolid for 10 days for acute bacterial skin and skin-structure infections (ESTABLISH-2): a randomised, double-blind, phase 3, non-inferiority trial. www.ncbi.nlm.nih.gov 2014年 Lancet Inf Disに…

ESTABLISH-1 : Tedizolid phosphate vs linezolid for treatment of acute bacterial skin and skin structure infections: the ESTABLISH-1 randomized trial.

ESTABLISH-1 : Tedizolid phosphate vs linezolid for treatment of acute bacterial skin and skin structure infections: the ESTABLISH-1 randomized trial. www.ncbi.nlm.nih.gov 2013年 JAMAに報告された、国際共同(アジアは含まれない)81施設 による…

Cranberries vs antibiotics to prevent urinary tract infections: a randomized double-blind noninferiority trial in premenopausal women.

RCT

Cranberries vs antibiotics to prevent urinary tract infections: a randomized double-blind noninferiority trial in premenopausal women. www.ncbi.nlm.nih.gov 2011年 Arch Intern Medに報告された、オランダにおける再発性尿路感染症を有する閉経前…

Effect of Cranberry Capsules on Bacteriuria Plus Pyuria Among Older Women in Nursing Homes: A Randomized Clinical Trial.

Effect of Cranberry Capsules on Bacteriuria Plus Pyuria Among Older Women in Nursing Homes: A Randomized Clinical Trial. 2016年 JAMAに報告された、米国nursing home 21施設における高齢者細菌尿・膿尿に対するクランベリーカプセル vs プラセボを比…

Antibiotic treatment for 6 weeks versus 12 weeks in patients with pyogenic vertebral osteomyelitis: an open-label, non-inferiority, randomised, controlled trial.

Antibiotic treatment for 6 weeks versus 12 weeks in patients with pyogenicvertebral osteomyelitis: an open-label, non-inferiority, randomised, controlledtrial. 2015年 (Epub2014年) Lancetに報告された、フランス71施設における化膿性脊椎炎患者…

Journal Club : MODIFY I and MODIFY II ; Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection

Journal Club : Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection. MODIFY I and MODIFY II 今週のプレゼンターは、感染症看護専門看護師 2017年1月NEJMに報告された、日本を含む30カ国322施設におけるC. difficile の初感染また…

Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: a randomized clinical trial.

Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: a randomized clinical trial. www.ncbi.nlm.nih.gov 2015年JAMAに報告された、スペイン3施設によ…

Adjunct prednisone therapy for patients with community-acquired pneumonia: a multicentre, double-blind, randomised, placebo-controlled trial.

Adjunct prednisone therapy for patients with community-acquired pneumonia: a multicentre, double-blind, randomised, placebo-controlled trial. www.ncbi.nlm.nih.gov 2015年Lancetに報告された、スイス7施設による成人の市中肺炎に対するプレドニゾ…

Efficacy and safety of oral solithromycin versus oral moxifloxacin for treatment of community-acquired bacterial pneumonia: a global, double-blind, multicentre, randomised, active-controlled, non-inferiority trial (SOLITAIRE-ORAL).

SOLITAIRE-ORAL : Efficacy and safety of oral solithromycin versus oral moxifloxacin for treatment of community-acquired bacterial pneumonia: a global, double-blind, multicentre, randomised, active-controlled, non-inferiority trial. www.ncb…

Antibiotic treatment strategies for community-acquired pneumonia in adults.

CAP-START : Antibiotic treatment strategies for community-acquired pneumonia in adults. www.ncbi.nlm.nih.gov 2015年NEJMに報告された、オランダ7施設による成人の市中肺炎に対する抗菌薬治療戦略.

Frozen vs Fresh Fecal Microbiota Transplantation and Clinical Resolution of Diarrhea in Patients With Recurrent Clostridium difficile Infection: A Randomized Clinical Trial.

Frozen vs Fresh Fecal Microbiota Transplantation and Clinical Resolution of Diarrhea in Patients With Recurrent Clostridium difficile Infection: A Randomized Clinical Trial. www.ncbi.nlm.nih.gov 2016年JAMAに報告された、カナダ6施設によるCDI…

Simvastatin in the acute respiratory distress syndrome

Simvastatin in the acute respiratory distress syndrome www.ncbi.nlm.nih.gov 2014年NEJMに報告された、英国40施設ICUによるARDSに対するスタチンRCT。

Journal Club : Brigatinib in Patients With Crizotinib-Refractory Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer: A Randomized, Multicenter Phase II Trial. ALTA trial

Journal Club : Brigatinib in Patients With Crizotinib-Refractory Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer: A Randomized, Multicenter Phase II Trial. www.ncbi.nlm.nih.gov 今週のプレゼンターは、呼吸器内科医 2017年JCOに…

Lovastatin for the Treatment of Adult Patients With Dengue: A Randomized, Double-Blind, Placebo-Controlled Trial.

Lovastatin for the Treatment of Adult Patients With Dengue: A Randomized, Double-Blind, Placebo-Controlled Trial. www.ncbi.nlm.nih.gov 2016年CIDに報告された、ベトナム2施設によるデング熱に対するRCT。 スタチンとプラセボの比較。スタチンの抗炎…

Clindamycin versus trimethoprim-sulfamethoxazole for uncomplicated skin infections

Clindamycin versus trimethoprim-sulfamethoxazole for uncomplicated skin infections. www.ncbi.nlm.nih.gov 2015年NEJMに報告された、米国4施設による単純性皮膚感染症に対するRCT。 クラシカルなSTとクリンダマイシン比較。

Trimethoprim-Sulfamethoxazole versus Placebo for Uncomplicated Skin Abscess.

Trimethoprim-Sulfamethoxazole versus Placebo for Uncomplicated Skin Abscess. www.ncbi.nlm.nih.gov 2016年NEJMに報告された、米国5施設による単純性皮膚膿瘍に対するRCT。 クラシカルなSTのプラセボ比較。

CAMERA : Combination of Vancomycin and β-Lactam Therapy for Methicillin-Resistant Staphylococcus aureus Bacteremia: A Pilot Multicenter Randomized Controlled Trial.

CAMERA study Combination of Vancomycin and β-Lactam Therapy for Methicillin-Resistant Staphylococcus aureus Bacteremia: A Pilot Multicenter Randomized Controlled Trial. オーストラリア7施設によるMRSA菌血症に対する併用療法パイロットRCT 新薬…

Trimethoprim-sulfamethoxazole versus vancomycin for severe infections caused by meticillin resistant Staphylococcus aureus: randomised controlled trial.

Trimethoprim-sulfamethoxazole versus vancomycin for severe infections caused by meticillin resistant Staphylococcus aureus: randomised controlled trial. www.ncbi.nlm.nih.gov 2015年に報告された、イスラエルのRCT 重症MRSA感染患者に対する、ST …

Efficacy and safety of ridinilazole compared with vancomycin for the treatment of Clostridium difficile infection: a phase 2, randomised, double-blind, active-controlled, non-inferiority study

The Lancet Infectious Diseases Published: April 28, 2017 Efficacy and safety of ridinilazole compared with vancomycin for the treatment of Clostridium difficile infection: a phase 2, randomised, double-blind, active-controlled, non-inferio…